Bcl-3 induced by IL-22 via STAT3 activation acts as a potentiator of psoriasis-related gene expression in epidermal keratinocytes
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
IL-22 induces STAT3 phosphorylation and mediates psoriasis-related gene expression. However, the signaling mechanism leading from pSTAT3 to the expression of these genes remains unclear. We focused on Bcl-3, which is induced by STAT3 activation and mediates gene expression. In cultured human epidermal keratinocytes, IL-22 increased Bcl-3, which was translocated to the nucleus with p50 via STAT3 activation. The increases in CXCL8, S100As and human β-defensin 2 mRNA expression caused by IL-22 were abolished by siRNA against Bcl-3. Although CCL20 expression was also augmented by IL-22, the knockdown of Bcl-3 increased its level. Moreover, the combination of IL-22 and IL-17A enhanced Bcl-3 production, IL-22-induced gene expression, and the expression of other psoriasis-related genes, including those encoding IL-17C, IL-19, and IL-36γ. The expression of these genes (except for CCL20) was also suppressed by the knockdown of Bcl-3. Bcl-3 overexpression induced CXCL8 and HBD2 expression but not S100As expression. We also compared Bcl-3 expression between psoriatic skin lesions and normal skin. Immunostaining revealed strong signals for Bcl-3 and p50 in the nucleus of epidermal keratinocytes from psoriatic skin. The IL-22-STAT3-Bcl-3 pathway may be important in the pathogenesis of psoriasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“NF-κB subsequently upregulates expression of IκBζ and Bcl3, noncanonical members of the NF-κB family that in turn promote expression of various IL-17-NF-κB driven pro-inflammatory and anti-microbial genes”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Tohyama et al., 2018
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330 · cited 7×
“The combination of IL-22 and IL-17A synergistically enhanced the mRNA expression of CXCL8, CCL20, S100As, and HBD2 C© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu [4, 15, 26].”
BackgroundInfluentialLowes, M. A., Suárez-Fariñas, M., & Krueger, J. G. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120225 · Cited by 1,650
IL-22 Increases the Innate Immunity of Tissues
Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K., & Sabat, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.007 · Cited by 1,359
Sonnenberg, G. F., Fouser, L. A., & Artis, D. (2011) · Nature Immunology · doi:10.1038/ni.2025 · Cited by 1,044
Wolk, K., Witte, E., Wallace, E., Döcke, W., Kunz, S., Asadullah, K., Volk, H., Sterry, W., & Sabat, R. (2006) · European Journal of Immunology · doi:10.1002/eji.200535503 · Cited by 922
Sano, S., Chan, K. S., Carbajal, S., Clifford, J., Peavey, M., Kiguchi, K., Itami, S., Nickoloff, B. J., & DiGiovanni, J. (2005) · Nature Medicine · doi:10.1038/nm1162 · Cited by 752 · cited 1×
“Several studies have revealed important roles for STAT3 activation in the pathogenesis of psoriasis [9, 10], and STAT3 is the principal mediator of IL-22 signaling [11, 12].”
BackgroundTherapeutic opportunities of the IL-22–IL-22R1 system
Sabat, R., Ouyang, W., & Wolk, K. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4176 · Cited by 562
Sa, S. M., Valdez, P. A., Wu, J., Jung, K., Zhong, F., Hall, L., Kasman, I., Winer, J., Modrusan, Z., Danilenko, D. M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2229 · Cited by 514
Bours, V (1993) · Cell · doi:10.1016/0092-8674(93)90401-b · Cited by 495
The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin
Weaver, C. T., Elson, C. O., Fouser, L. A., & Kolls, J. K. (2013) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130318 · Cited by 462 · cited 1×
“It is thought that IL-22 and IL-17A mediate gene expression in the inflammatory response of psoriasis [7, 8].”
Background
Research works printed but not linked: 1
- C 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu 15214141, 2018, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/eji.201747017 by Readcube (Labtiva Inc.), Wiley Online Library on [21/08/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
Cited by
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“NF-κB subsequently upregulates expression of IκBζ and Bcl3, noncanonical members of the NFκB family that in turn promote expression of various IL-17-NF-κB driven pro-inflammatory and anti-microbial genes (Karlsen et al., 2010; Ruddy et al., 2004; Tohyama et al., 2018).”
BackgroundThe role of Th17 cells in psoriasis
Li, B., Huang, L., Lv, P., Li, X., Liu, G., Chen, Y., Wang, Z., Qian, X., Shen, Y., Li, Y., et al. (2020) · Immunologic Research · doi:10.1007/s12026-020-09149-1 · Cited by 162
Resident Memory T Cells in Autoimmune Skin Diseases
Ryan, G. E., Harris, J. E., & Richmond, J. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.652191 · Cited by 132
Ma, C., Gu, C., Lian, P., Wazir, J., Lu, R., Ruan, B., Wei, L., Li, L., Pu, W., Peng, Z., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06234-9 · Cited by 114
Tissue-resident immune cells: from defining characteristics to roles in diseases
Li, J., Chu, X., Li, C., & He, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02050-5 · Cited by 102
Saran, A., Nishizaki, D., Lippman, S. M., Kato, S., & Kurzrock, R. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.01.002 · Cited by 71
Importance of lymphocyte–stromal cell interactions in autoimmune and inflammatory rheumatic diseases
Noack, M., & Miossec, P. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00665-4 · Cited by 65
The Double Game Played by Th17 Cells in Infection: Host Defense and Immunopathology
Paroli, M., Caccavale, R., Fiorillo, M. T., Spadea, L., Gumina, S., Candela, V., & Paroli, M. P. (2022) · Pathogens · doi:10.3390/pathogens11121547 · Cited by 62
Dai, X., Muto, J., Shiraishi, K., Utsunomiya, R., Mori, H., Murakami, M., & Sayama, K. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.01.005 · Cited by 62
Self-citationIL-18/IL-18BP and IL-22/IL-22BP: Two interrelated couples with therapeutic potential
Mühl, H., & Bachmann, M. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109388 · Cited by 53
Characteristics and sources of tissue-resident memory T cells in psoriasis relapse
Dong, C., Lin, L., & Du, J. (2023) · Current Research in Immunology · doi:10.1016/j.crimmu.2023.100067 · Cited by 51
The Immune Function of Keratinocytes in Anti-Pathogen Infection in the Skin
Wang, J., & Li, M. (2020) · International Journal of Dermatology and Venereology · doi:10.1097/jd9.0000000000000094 · Cited by 51
Konger, R. L., Derr-Yellin, E. C., Zimmers, T. A., Katona, T. M., Xuei, X., Liu, Y., Zhou, H., Simpson, E. R., & Turner, M. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168634 · Cited by 41
Legge, D., Shephard, A. P., Collard, T. J., Greenhough, A., Chambers, A., Clarkson, R. W. E., Paraskeva, C., & Williams, A. C. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.037697 · Cited by 39
Gao, L., Dou, J., Zhang, B., Zeng, J., Cheng, Q., Lei, L., Tan, L., Zeng, Q., Ding, S., Guo, A., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15160 · Cited by 31
Shah, F., Giri, P. S., Bharti, A. H., & Dwivedi, M. (2023) · Experimental Dermatology · doi:10.1111/exd.14982 · Cited by 31
Participation of interferons in psoriatic inflammation
Gu, H., Zhang, Y., Zeng, W., & Xia, Y. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.12.002 · Cited by 30
The Role of T Helper 22 Cells in Dermatological Disorders
Pan, Y., Du, D., Wang, L., Wang, X., He, G., & Jiang, X. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.911546 · Cited by 30
FUT8 Remodeling of EGFR Regulates Epidermal Keratinocyte Proliferation during Psoriasis Development
Kelel, M., Yang, R., Tsai, T., Liang, P., Wu, F.-Y., Huang, Y.-T., Yang, M.-F., Hsiao, Y., Wang, L., Tu, C.-F., et al. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.07.030 · Cited by 26
Zhang, J., Zhu, J., Chen, X., Xia, H., & Yang, L. (2022) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2022.09.002 · Cited by 26
Visser, M. J. E., Tarr, G. S., & Pretorius, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.688861 · Cited by 24
Cytokines in psoriasis: From pathogenesis to targeted therapy
Alsabbagh, M. M. (2024) · Human Immunology · doi:10.1016/j.humimm.2024.110814 · Cited by 21
Critical role of keratinocytes in cutaneous immune responses
Gupta, R. K., Wasnik, P., Mondal, D., & Shukla, D. (2024) · Exploration of Immunology · doi:10.37349/ei.2024.00155 · Cited by 21
Small molecules under development for psoriasis: on the road to the individualized therapies
Cervantes‐Durán, C., María-Elena, V.-H., Valentin‐Escalera, J., Bartolomé‐Camacho, M. C., Rodríguez-Orozco, A. R., & García‐Pérez, M. (2020) · Archives of Dermatological Research · doi:10.1007/s00403-020-02056-3 · Cited by 21
Dai, X., Murakami, M., Shiraishi, K., Muto, J., Tohyama, M., Mori, H., Utsunomiya, R., & Sayama, K. (2022) · European Journal of Immunology · doi:10.1002/eji.202149706 · Cited by 21
Self-citationYang, Y., Chen, Y., Yu, L., Zhang, X., Shang, J., Fan, J., Zhang, R., Ren, J., & Duan, X. (2022) · Inflammation Research · doi:10.1007/s00011-022-01674-z · Cited by 21
Huang, K., Lin, M.-N., Hsu, H.-C., Hsu, Y., Huang, T.-N., Lu, I.-H., & Pan, I.-H. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/7729836 · Cited by 14
Ran, L., Wang, H., Lan, D., Jia, H., & Yu, S. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.239297 · Cited by 13
Zhuang, W., Zhang, Q., Kong, Q., Hui, Y., Shen, J., Zhang, C., Sang, H., & Ye, Q. (2025) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s541106 · Cited by 10
Acitretin-Conjugated Dextran Nanoparticles Ameliorate Psoriasis-like Skin Disease at Low Dosages
Lan, J., Li, Y., Wen, J., Chen, Y., Yang, J., Zhao, L., Xia, Y., Du, H., Tao, J., Li, Y., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.816757 · Cited by 10
Patel, J., Deng, J., Kambala, A., Lee, K. K., Cornman, H. L., Parthasarathy, V., Pritchard, T., Chen, S., Hernandez, A., Shin, S. M., et al. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.01.036 · Cited by 9
Deucravacitinib and shikonin combination therapy ameliorates imiquimod-induced psoriasis in mice
Xu, L., Jiang, Y. Y., Fu-ping, X., Liu, J., Jiang, Y., Fang, F., & Luo, L. (2024) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320241260262 · Cited by 8
Roles of tumor necrosis factor-like ligand 1A in γδT-cell activation and psoriasis pathogenesis
Wang, S., Kozai, M., Hiraishi, M., Rubel, M. Z. U., Ichii, O., Inaba, M., Matsuo, K., & Takada, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1340467 · Cited by 7
Knockdown of Bcl-3 alleviates psoriasis and dyslipidemia comorbidity by regulating Akt pathway
Li, W., Yang, W., & Yang, C. (2022) · Allergologia et Immunopathologia · doi:10.15586/aei.v50i6.683 · Cited by 5
Li, J., Qiu, H., Li, S., Han, S., He, Y., He, J., Gao, X., Li, J., Feng, J., Yang, S., et al. (2024) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2024.04.001 · Cited by 5
Talmaç, A. G. Ö., Koç, A., & Kavut, B. S. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-024-03708-4 · Cited by 2
Wang, H., Ding, Y., Zhao, Y., Liu, X., Zhang, Y., & Wu, W. (2022) · European Journal of Inflammation · doi:10.1177/1721727x221145431 · Cited by 1
The roles of MCPyV early region in IL-17A-mediated inflammation and autophagy
Miao, J. (2021) · theses.fr (ABES) · doi:10.70675/0ed263f9za522z491ezb888z3d6d2826cd2b
Small Molecule Inhibitors Targeting Protein–Protein Interactions in the BCL Protein
Zhu, W., He, Y., Chen, G., & Zhu, D. (2025) · Wiley eBooks · doi:10.1002/9783527845828.ch12
Bcl-3 expression in the imiquimod-induced psoriasis mouse skin
Hernández-Valenzuela, M. A., Martínez-Rebollo, J. C., Cancino‐Díaz, J. C., Sánchez-Torres, M. M., Gómez‐Chávez, F., Pérez‐Hernández, E., Rodríguez–Martínez, S., & Cancino-Diaz, M. E. (2026) · BMC Research Notes · doi:10.1186/s13104-026-07741-6
Mahmud, M. A., Mohyeldin, M. M., Tarun, M. T. I., Siddique, A. B., Singh, S. S., & Sayed, K. A. E. (2026) · Journal of Natural Medicines · doi:10.1007/s11418-026-02015-8
γδT細胞の新規制御経路とこれを標的とした乾癬の治療戦略に関する研究
Wang, S. (2024) · Institutional Repositories DataBase (IRDB) · doi:10.14943/doctoral.k16158
Jl, P., Xu, Y., Chen, Y., Zhu, J. F., Song, Y., & Cheng, H. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117164
Supporting information 1 of The Role of T Helper 22 Cells in Dermatological Disorders
Pan, Y., Du, D., Wang, L., Wang, X., He, G., & Jiang, X. (2022) · doi:10.3389/fimmu.2022.911546.s001
Wang, S., Kozai, M., Hiraishi, M., Rubel, M. Z. U., Ichii, O., Inaba, M., Matsuo, K., & Takada, K. (2024) · doi:10.3389/fimmu.2024.1340467.s001
Metadata
- Authors
- Tohyama, M., Shirakata, Y., Hanakawa, Y., Dai, X., Shiraishi, K., Murakami, M., Miyawaki, S., Mori, H., Utsunomiya, R., Masuda, K., Hashimoto, K., & Sayama, K.
- Affiliations
- Ehime University (JP)
- Corresponding author
- Tohyama, Mikiko
- ORCID
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2017-11-20
- Volume
- 48
- Issue
- 1
- Pages
- 168-179
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2754930357
- Cited by
- 41
- References
- 50
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 3 · 2022: 10 · 2021: 5 · 2020: 5 · 2019: 3 · 2018: 1
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Osaka University
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Keywords
- Bcl-3, IL-22, STAT3 activation, psoriasis, epidermal keratinocytes, P50, interleukin-8, human beta-defensin 2, S100A, CCL20, IL-17A, IL-17C, IL-19, IL-36γ, psoriatic lesions, transcriptional regulation
- MeSH terms
- B-Cell Lymphoma 3 Protein, Interleukin-22, Cells, Cultured, Enzyme Activation, Gene Expression Regulation, Humans, Interleukin-1, Interleukins, S100 Proteins, Phosphorylation, Proto-Oncogene Proteins, Psoriasis, RNA, Messenger, Skin, Transcription Factors, Keratinocytes, Interleukin-8, Interleukin-17, Active Transport, Cell Nucleus, beta-Defensins, RNA Interference, RNA, Small Interfering, STAT3 Transcription Factor, NF-kappa B p50 Subunit, Chemokine CCL20
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.